Related Experiment Video
Updated: Nov 21, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
MiR-103-3p targets the m6 A methyltransferase METTL14 to inhibit osteoblastic bone formation
Zhongyang Sun1,2, Han Wang3, Yuxiang Wang1
1Department of Orthopedics, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Abstract:
Impaired osteoblast function is involved in osteoporosis, and microRNA (miRNA) dysregulation may cause abnormal osteoblast osteogenic activity. However, the influence of miRNA on osteoblast activity and the underlying mechanisms remain elusive. In this study, miR-103-3p was found to be negatively correlated with bone formation in bone specimens from elderly women with fractures and ovariectomized (OVX) mice. Additionally, miR-103-3p directly targeted Mettl14 to inhibit osteoblast activity, and METTL14-dependent N6 -methyladenosine (m6 A) methylation inhibited miR-103-3p processing by the microprocessor protein DGCR8 and promoted osteoblast activity. Moreover, miR-103-3p inhibited bone formation in vivo, and therapeutic inhibition of miR-103-3p counteracted the decreased bone formation in OVX mice. Further, METTL14 was negatively correlated with miR-103-3p but positively correlated with bone formation in bone specimens from elderly women with fractures and OVX mice. Collectively, our results highlight the critical roles of the miR-103-3p/METTL14/m6 A signaling axis in osteoblast activity, identifying this axis as a potential target for ameliorating osteoporosis.
Insights
MicroRNA-103-3p impairs bone formation by inhibiting osteoblast activity. Targeting this microRNA and its interaction with METTL14 and m6A methylation may offer new osteoporosis treatments.
Area of Science:
- Molecular Biology
- Cell Biology
- Bone Biology
Background:
- Osteoporosis is linked to impaired osteoblast function.
- MicroRNA (miRNA) dysregulation can disrupt osteoblast activity, but mechanisms are unclear.
Purpose of the Study:
- Investigate the role of miR-103-3p in osteoblast activity and bone formation.
- Elucidate the molecular mechanisms involving miR-103-3p, METTL14, and N6-methyladenosine (m6A) methylation in osteoporosis.
Main Methods:
- Correlation analysis in human bone specimens and ovariectomized (OVX) mouse models.
- In vivo and in vitro experiments to assess miR-103-3p targeting of Mettl14.
- Analysis of METTL14-dependent m6A methylation's effect on miR-103-3p processing and osteoblast activity.
Main Results:
- miR-103-3p negatively correlated with bone formation and osteoblast activity.
- miR-103-3p directly targets Mettl14, inhibiting osteoblast function.
- METTL14-dependent m6A methylation promotes osteoblast activity by inhibiting miR-103-3p processing.
- Inhibition of miR-103-3p in OVX mice improved bone formation.
Conclusions:
- The miR-103-3p/METTL14/m6A signaling axis is crucial for osteoblast activity.
- This axis represents a potential therapeutic target for osteoporosis treatment.
Related Concept Videos
MicroRNAs
MicroRNAs

